Form 4: Sotera Health Director James Neary Receives Equity Grant of 19,132 Restricted Stock Units

Sotera Health Co. Director James Neary was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of his compensation, aligning his interests with shareholders.

Summary

• James Neary, a Director of Sotera Health Co. (SHC), acquired 19,132 shares of Common Stock on May 22, 2025.
• These securities are Restricted Stock Units (RSUs) granted under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock, subject to specific vesting conditions.
• The RSUs will vest in full on the earlier of the first anniversary of the grant date (May 22, 2026) or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on Mr. Neary's continued service as a non-employee director.
• Following this transaction, Mr. Neary beneficially owns a total of 80,781 securities, comprising the 19,132 newly granted RSUs and 61,649 shares of Common Stock.

Sentiment

Score: 7

Explanation: The document reports a routine equity grant to a director, which is a positive for governance and alignment of interests, but not a significant market-moving event. It reflects standard compensation practices.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• The transaction is part of a pre-existing incentive plan (Sotera Health Company 2020 Omnibus Incentive Plan), indicating a structured approach to executive and director compensation.

Future Outlook

The RSUs are subject to vesting conditions, which include continued service as a non-employee director until the earlier of the first anniversary of the grant date or the next annual shareholders meeting, indicating an expectation of continued board service.

Industry Context

It is a common practice in the corporate sector for non-employee directors to receive a portion of their compensation in the form of equity, such as Restricted Stock Units (RSUs), to align their long-term interests with those of the company's shareholders. This practice is widely adopted across various industries to incentivize performance and retention.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is a standard compensation practice across publicly traded companies, including those in the healthcare and industrial services sectors like Sotera Health.
• Companies such as Steris plc (STE) or Cantel Medical (CMN), which operate in related medical device sterilization or infection prevention markets, often utilize similar equity-based compensation structures for their board members.
• The vesting schedule, tied to continued service and a specific timeframe (one year or next annual meeting), is typical for director RSU grants, ensuring commitment and long-term perspective.

Corporate Governance

Related Party Transactions

• The grant of 19,132 Restricted Stock Units to James Neary, a director, constitutes a transaction with a related party. This is a standard form of non-cash compensation for board service, designed to align the director's financial interests with the company's performance.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with shareholders, potentially leading to more shareholder-centric decision-making.
• Employees: While not directly impacted, the incentive plan framework may also apply to other key personnel, fostering a performance-driven culture.

Next Steps

• The RSUs will vest in full on the earlier of May 22, 2026, or the date immediately prior to Sotera Health's next regular annual shareholders meeting, subject to continued service.

Key Dates

Keywords

Sotera Health, SHC, Form 4, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Insider Transaction, Incentive Plan, Corporate Governance